Camilla Normand

980 total citations
25 papers, 624 citations indexed

About

Camilla Normand is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Surgery. According to data from OpenAlex, Camilla Normand has authored 25 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Camilla Normand's work include Cardiac pacing and defibrillation studies (20 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Camilla Normand is often cited by papers focused on Cardiac pacing and defibrillation studies (20 papers), Cardiac Arrhythmias and Treatments (15 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Camilla Normand collaborates with scholars based in Norway, Sweden and Germany. Camilla Normand's co-authors include Peter J. Edmonds, Y Saunders, J R Ross, Karen Broadley, David Wonderling, Kenneth Dickstein, Cecilia Linde, Jagmeet P. Singh, Thomas J. Povsic and David M. Kaye and has published in prestigious journals such as The Lancet, Heart and Health Technology Assessment.

In The Last Decade

Camilla Normand

20 papers receiving 610 citations

Peers

Countries citing papers authored by Camilla Normand

Since Specialization

Citations

This map shows the geographic impact of Camilla Normand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Normand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Normand more than expected).

Fields of papers citing papers by Camilla Normand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Normand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Normand. The network helps show where Camilla Normand may publish in the future.

Co-authorship network of co-authors of Camilla Normand

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Normand. A scholar is included among the top collaborators of Camilla Normand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Normand. Camilla Normand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Machine learning-based prediction of 1-year all-cause mortality in patients undergoing CRT implantation: validation of the SEMMELWEIS-CRT score in the European CRT Survey I dataset 2024 ·European Heart Journal - Digital Health ·Márton Tokodi, Annamária Kosztin, Attila Kovács, László Gellér, (unknown), (unknown), (unknown), (unknown), Nigussie Bogale, Cecilia Linde, Camilla Normand, Kenneth Dickstein, Béla Merkely	0
2	What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II 2023 ·European Heart Journal - Quality of Care and Clinical Outcomes ·(unknown), Cecilia Linde, Lina Benson, Tonje Thorvaldsen, Camilla Normand, Gianluigi Savarese, Ulf Dahlström, Aldo P. Maggioni, Kenneth Dickstein, Lars H. Lund	6
3	Upgrades from Previous Cardiac Implantable Electronic Devices Compared to De Novo Cardiac Resynchronization Therapy Implantations: Results from CRT Survey-II in the Turkish Population 2022 ·PubMed ·Duygu Koçyiğit, (unknown), Timuçin Altın, Serkan Çay, Camilla Normand, Cecilia Linde, Kenneth Dickstein, (unknown), (unknown)	1
4	Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II 2020 ·EP Europace ·Camilla Normand, Cecilia Linde, Carina Blomström‐Lundqvist, Christoph Stellbrink, Maurizio Gasparini, Stefan D. Anker, Chris Plummer, (unknown), Giorgi Papiashvili, (unknown), Kenneth Dickstein	8
5	Beyond pharmacological treatment: an insight into therapies that target specific aspects of heart failure pathophysiology 2019 ·The Lancet ·Camilla Normand, David M. Kaye, Thomas J. Povsic, Kenneth Dickstein	48
6	Sex-Related Procedural Aspects and Complications in CRT Survey II 2019 ·JACC. Clinical electrophysiology ·Angelo Auricchio, Maurizio Gasparini, Cecilia Linde, Dan Dobreanu, Óscar Cano, Maciej Sterliński, Nigussie Bogale, Christoph Stellbrink, Marwan M. Refaat, Carina Blomström‐Lundqvist, (unknown), Kenneth Dickstein, Camilla Normand	9
7	Cardiac resynchronization in Poland – comparable procedural routines? Insights from CRT Survey II 2019 ·Advances in Interventional Cardiology ·Mateusz Tajstra, (unknown), Elżbieta Gadula‐Gacek, (unknown), (unknown), Dariusz Wojciechowski, (unknown), Maciej Kempa, Zbigniew Orski, Anna Polewczyk, (unknown), Camilla Normand, Kenneth Dickstein, Cecilia Linde, Jarosław Kaźmierczak, Łukasz Szumowski, Mariusz Gąsior, Maciej Sterliński	2
8	Comparison of current German and European practice in cardiac resynchronization therapy: lessons from the ESC/EHRA/HFA CRT Survey II 2019 ·Clinical Research in Cardiology ·(unknown), (unknown), Carsten W. Israel, Cecilia Linde, Camilla Normand, Kenneth Dickstein, (unknown), Anselm K. Gitt, Gerhard Hindricks, Christoph Stellbrink	3
9	Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator: what determines the choice?—findings from the ESC CRT Survey II 2019 ·EP Europace ·Camilla Normand, Cecilia Linde, Nigussie Bogale, Carina Blomström‐Lundqvist, Angelo Auricchio, Christoph Stellbrink, Klaus K. Witte, Wilfried Müllens, Christian Sticherling, Germanas Marinskis, Elena Sciaraffia, Giorgi Papiashvili, (unknown), Kenneth Dickstein	9
10	The European Society of Cardiology Cardiac Resynchronization Therapy Survey II: A comparison of cardiac resynchronization therapy implantation practice in Europe and France 2019 ·Archives of cardiovascular diseases ·Vincent Galand, Cecilia Linde, Nicolas Lellouche, Jacques Mansourati, Jean‐Claude Deharo, (unknown), Antoine Da Costa, (unknown), Pascal Defaye, Serge Bovéda, (unknown), Paul Bru, (unknown), T Béard, (unknown), Kenneth Dickstein, Camilla Normand, Christophe Leclercq	0
11	Do we differ in terms of indications and demographics in cardiac resynchronisation recipients in Poland? Insights from the European CRT Survey II Registry 2018 ·Kardiologia Polska ·(unknown), Maciej Sterliński, Mateusz Tajstra, Krystian Josiak, (unknown), (unknown), Adam Sokal, Łukasz Januszkiewicz, (unknown), (unknown), Jarosław Kaźmierczak, Łukasz Szumowski, Camilla Normand, Cecilia Linde, Kenneth Dickstein	4
12	Upgrades from a Previous Device Compared to De Novo Cardiac Resynchronization Therapy in the European Society of Cardiology CRT Survey II 2018 ·European Journal of Heart Failure ·Cecilia Linde, Camilla Normand, Nigussie Bogale, Angelo Auricchio, Maciej Sterliński, Germanas Marinskis, Christian Sticherling, Alan Bulava, Óscar Cano Pérez, Alexander H. Maass, Klaus K. Witte, (unknown), S Abdelali, Kenneth Dickstein	33
13	Indications for Cardiac Resynchronization Therapy 2018 ·JACC Heart Failure ·Camilla Normand, Cecilia Linde, Jagmeet P. Singh, Kenneth Dickstein	53
14	Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland 2018 ·Swiss Medical Weekly ·(unknown), Haran Burri, Alexander Breitenstein, Peter Ammann, Andreas S. Mueller, Angelo Auricchio, Etienne Delacrétaz, Kenneth Dickstein, Cecilia Linde, Camilla Normand, Christian Sticherling	0
15	Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry 2018 ·Cardiology Research and Practice ·Sandro Brusich, (unknown), Nikola Pavlović, Ante Anić, Zrinka Jurišić, (unknown), (unknown), (unknown), Kenneth Dickstein, Cecilia Linde, Camilla Normand, Šime Manola	1
16	European Cardiac Resynchronization Therapy Survey II: rationale and design 2014 ·EP Europace ·Kenneth Dickstein, Camilla Normand, Stefan D. Anker, Angelo Auricchio, Carina Blomström‐Lundqvist, Nigussie Bogale, John G.F. Cleland, Gerasimos Filippatos, Maurizio Gasparini, Anselm Gitt, Gerhard Hindricks, Karl‐Heinz Kück, Piotr Ponikowski, Christoph Stellbrink, Frank Ruschitzka, Cecilia Linde	15
17	Health Management Program: Factors Influencing Completion of Therapy with High-Dose Interferon Alfa-2b for High-Risk Melanoma 2008 ·Current Oncology ·Nadja Levesque, (unknown), (unknown), (unknown), David MacDonald, Camilla Normand, Jean‐François Pouliot	15
18	Benefits of hydration in patients receiving intron A therapy for high-risk melanoma: a nursing support program to minimize drug-related side effects 2006 ·Melanoma Research ·Nadja Levesque, (unknown), (unknown), (unknown), (unknown), Camilla Normand, (unknown)	2
19	A systematic review of the role of bisphosphonates in metastatic disease 2004 ·Health Technology Assessment ·J R Ross, Y Saunders, Peter J. Edmonds, (unknown), David Wonderling, Camilla Normand, Karen Broadley	387
20	Health economic burden of non-ST-segment elevation acute coronary syndromes in Europe. Results from PRAIS-UK 2001 ·LSHTM Research Online (London School of Hygiene and Tropical Medicine) ·Ameet Bakhai, (unknown), J Collinson, Camilla Normand, James A. Coles, Marcus Flather, Brant R. Ward	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact